Bright Minds Financials

Trends View

Profitability View

Liquidity View

Fundamentals View

Competition View

Bright Minds Stock Summary

Bright Minds competes with Revelation Biosciences, Zura Bio, Phio Pharmaceuticals, ZyVersa Therapeutics, and Transcode Therapeutics. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States.

Bright Minds Key Financial Ratios

Bright Minds Key Balance Sheet Accounts

Bright Minds Key Cash Accounts

Bright Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bright Minds's current stock value. Our valuation model uses many indicators to compare Bright Minds value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bright Minds competition to find correlations between indicators driving Bright Minds's intrinsic value. More Info.Bright Minds Biosciences is rated # 3 in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At this time, Bright Minds' Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Bright Minds by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Bright Minds Biosciences Systematic Risk

Today, most investors in Bright Minds Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bright Minds' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Bright Minds growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Bright Minds help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bright Minds Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bright Minds Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Bright Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bright Minds's daily price indicators and compare them against related drivers.

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.